eMedicine Specialties > Cardiology > Arrhythmias

Atrioventricular Nodal Reentry Tachycardia (AVNRT)

Author: Brian Olshansky, MD, Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine
Coauthor(s): Chirag M Sandesara, MD, Fellow, Department of Internal Medicine, Division of Cardiovascular Diseases, University of Iowa Hospitals and Clinics; Mukesh Garg, MD, MRCP, Assistant Professor, Department of Internal Medicine, Section of Cardiology, Truman Medical Center, University of Missouri at Kansas City; Annette Quick, MD, Medical Director, Cardiovascular Care Unit, Associate Professor, Department of Medicine, University of Missouri at Kansas City; Marco A Barzallo, MD, Consulting Staff, HeartCare Midwest, SC
Contributor Information and Disclosures

Updated: Jun 11, 2009

Introduction

Background

Atrioventricular nodal reentry tachycardia (AVNRT) is the most common type of reentrant supraventricular tachycardia (SVT). Because of the abrupt onset and termination of the reentrant SVT, the nonspecific term paroxysmal supraventricular tachycardia (or even the misleading term paroxysmal atrial tachycardia [PAT]) has been used to refer to these tachyarrhythmias. With improved knowledge of the electrophysiology of reentrant SVT, more specific nomenclature based on the mechanism of reentry helps in better classifying these arrhythmias and thus helps in choosing appropriate therapies.

Pathophysiology

The substrate for AVNRT may be functional rather than anatomic. These arrhythmias occur in young, healthy patients and in those with chronic heart disease.

In patients with atrioventricular (AV) nodal reentry, the AV node is functionally divided into 2 longitudinal pathways that form the reentrant circuit. In the majority of patients, during AVNRT, antegrade conduction occurs to the ventricle over the slow (alpha) pathway and retrograde conduction occurs over the fast (beta) pathway (see Media file 1). In most patients with this arrhythmia, the tachycardia is initiated when a fortuitously timed atrial premature complex is blocked in the fast pathway (longer refractory period) and conducts in the slow pathway (shorter refractory period) (see Media file 1). While the impulse conducts to the ventricle in the slow pathway (antegrade conduction), the fast pathway recovers so that the impulse can conduct retrograde up the fast pathway to the atrium and the atrial end of the slow pathway (retrograde conduction).

Electrophysiological mechanism of atrioventricula...

Electrophysiological mechanism of atrioventricular nodal reentry tachycardia.

Electrophysiological mechanism of atrioventricula...

Electrophysiological mechanism of atrioventricular nodal reentry tachycardia.



This sets up the reentrant circuit. In approximately one third of patients, AVNRT is induced by premature ventricular stimulation. In addition to the typical mechanism of AV nodal reentry described above, atypical AV nodal reentry can occur in the opposite direction, with antegrade conduction in the fast pathway and retrograde conduction in the slow pathway. Less commonly, the reentrant circuit can be over 2 slow pathways, the so-called slow-slow AV node reentry.

Frequency

United States

AVNRT occurs in 60% of patients (with a female predominance) presenting with paroxysmal SVT. The prevalence of SVT in the general population is likely several cases per thousand persons.

International

Frequency is similar to that in the United States.

Mortality/Morbidity

AVNRT is usually well tolerated; it often occurs in patients with no structural heart disease. In patients with coronary artery disease, AVNRT may cause angina or myocardial infarction. Prognosis for patients without heart disease is usually good.

Sex

More women than men have AVNRT.

Age

AVNRT may occur in persons of any age. It is common in young adults.

Clinical

History

  • AVNRT is characterized by an abrupt onset and termination of episodes.
  • Episodes may last from seconds to minutes to days.
  • In the absence of structural heart disease, it is usually well tolerated.
  • Common symptoms include palpitations, nervousness, anxiety, lightheadedness, neck and chest discomfort, and dyspnea. Polyuria can occur after termination of the episode (due to the release of atrial natriuretic factor).
  • AVNRT may cause or worsen heart failure in patients with poor left ventricular function.
  • It may cause angina or myocardial infarction in patients with coronary artery disease.
  • Syncope may occur in patients with a rapid ventricular rate or prolonged tachycardia due to poor ventricular filling, decreased cardiac output, hypotension, and reduced cerebral circulation. Syncope may also occur because of transient asystole when the tachycardia terminates, owing to tachycardia-induced depression of the sinus node.

Physical

  • The heart rate is usually rapid, ranging from 150-250 beats per minute (bpm). It is usually 180-200 bpm in adults and, in children, may exceed 250 bpm.
  • Hypotension may occur initially or with rapid ventricular rates and prolonged episodes.
  • Sometimes, initial hypotension evokes a sympathetic response that increases blood pressure and may terminate the tachycardia by an increase in vagal tone.
  • Signs of left heart failure may develop or worsen in patients with poor left ventricular function.

Causes

The substrate for AVNRT is the presence of dual AV nodal pathways. Age of onset varies from childhood to the teenage years or adulthood. Some patients do not present until their seventh or eighth decade or older. In contrast to a bypass tract, dual AV nodal physiology is often an acquired abnormality.

More on Atrioventricular Nodal Reentry Tachycardia (AVNRT)

Overview: Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Differential Diagnoses & Workup: Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Treatment & Medication: Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Follow-up: Atrioventricular Nodal Reentry Tachycardia (AVNRT)
Multimedia: Atrioventricular Nodal Reentry Tachycardia (AVNRT)
References

References

  1. Jackman WM, Beckman KJ, McClelland JH, et al. Treatment of supraventricular tachycardia due to atrioventricular nodal reentry, by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med. Jul 30 1992;327(5):313-8. [Medline].

  2. Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 7th ed. Philadelphia, Pa: WB Saunders; 2004.

  3. Fogoros RN. Electrophysiologic Testing (Practical Cardiac Diagnosis). 3rd ed. London, UK: Blackwell Science; 1999.

  4. Gursoy S, Steurer G, Brugada J, et al. Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med. Sep 10 1992;327(11):772-4. [Medline].

  5. Janse MJ, Anderson RH, McGuire MA, Ho SY. "AV nodal" reentry: Part I: "AV nodal" reentry revisited. J Cardiovasc Electrophysiol. Oct 1993;4(5):561-72. [Medline].

Further Reading

Keywords

tachycardia, atrioventricular nodal reentry tachycardia, AVNRT, atrial tachycardia, AV junctional tachycardia, reentrant supraventricular tachycardia, paroxysmal supraventricular tachycardia, tachyarrhythmia, arrhythmia, chronic heart disease, rhythm disorder, atrioventricular nodal reentry, AV nodal reentry, premature ventricular stimulation

Contributor Information and Disclosures

Author

Brian Olshansky, MD, Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine
Brian Olshansky, MD is a member of the following medical societies: American Autonomic Society, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American College of Sports Medicine, American Federation for Clinical Research, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, and New York Academy of Sciences
Disclosure: Guidant/Boston Scientific Honoraria Speaking and teaching; Medtronic Honoraria Speaking and teaching; Guidant/Boston Scientific Consulting fee Consulting; Reliant Grant/research funds Other; Novartis Honoraria Speaking and teaching; Novartis Consulting fee Consulting

Coauthor(s)

Chirag M Sandesara, MD, Fellow, Department of Internal Medicine, Division of Cardiovascular Diseases, University of Iowa Hospitals and Clinics
Chirag M Sandesara, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, and American Medical Association
Disclosure: Nothing to disclose.

Mukesh Garg, MD, MRCP, Assistant Professor, Department of Internal Medicine, Section of Cardiology, Truman Medical Center, University of Missouri at Kansas City
Mukesh Garg, MD is a member of the following medical societies: Royal College of Physicians
Disclosure: Nothing to disclose.

Annette Quick, MD, Medical Director, Cardiovascular Care Unit, Associate Professor, Department of Medicine, University of Missouri at Kansas City
Annette Quick, MD is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

Marco A Barzallo, MD, Consulting Staff, HeartCare Midwest, SC
Marco A Barzallo, MD is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

Medical Editor

Russell F Kelly, MD, Program Director, Assistant Professor, Department of Internal Medicine, Division of Cardiology, Cook County Hospital, Rush Medical College
Russell F Kelly, MD is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Marschall S Runge, MD, PhD, Charles and Anne Sanders Distinguished Professor of Medicine, Chairman, Department of Medicine, Vice Dean for Clinical Affairs, University of North Carolina at Chapel Hill School of Medicine
Marschall S Runge, MD, PhD is a member of the following medical societies: American Association for the Advancement of Science, American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Federation for Clinical Research, American Federation for Medical Research, American Heart Association, American Physiological Society, American Society for Clinical Investigation, American Society for Investigative Pathology, Association of American Physicians, Association of Professors of Cardiology, Association of Professors of Medicine, Southern Society for Clinical Investigation, and Texas Medical Association
Disclosure: Pfizer Honoraria Speaking and teaching; Merck Honoraria Speaking and teaching; Orthoclinica Diagnostica Consulting fee Consulting

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Jeffrey N Rottman, MD, Professor of Medicine and Pharmacology, Director, Clinical Cardiac Electrophysiology Fellowship Program, Vanderbilt University School of Medicine; Chief, Department of Cardiology, Nashville Veterans Affairs Medical Center
Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association and North American Society of Pacing and Electrophysiology (NASPE)
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.